Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Melanoma

Free Subscription 09.02.2026 2 Am J Dermatopathol 1 Am J Ophthalmol 1 Ann Surg Oncol 1 Br J Dermatol 1 Cancer 1 Clin Cancer Res 3 J Am Acad Dermatol 1 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. COLBERT MD, Holder K, Tekin B, Buonaccorsi JN, et al
   A Case of Malignant Melanoma With Numerous Wagner-Meissner-Like Bodies.
   Am J Dermatopathol. 2026 Feb 6. doi: 10.1097/DAD.0000000000003240.
   PubMed         Abstract available
   
   
2. RUSSOLILLO JK, Schaedler A, Hsia B, Silberstein PT, et al
   Comprehensive Genomic Profiling of Acral Melanoma: Insights From the AACR Project GENIE Database.
   Am J Dermatopathol. 2026 Feb 6. doi: 10.1097/DAD.0000000000003237.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
   Interferon Alpha-2a as Treatment for Primary Acquired Melanosis with Atypia (PAMwA) and for PAMwA surrounding conjunctival melanoma.
   Am J Ophthalmol. 2026 Jan 29:S0002-9394(26)00042.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. ZIJLKER LP, Verwer Z, van der Wiel BA, Kuijpers AMJ, et al
   ASO Visual Abstract: Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Primary Cutaneous Melanoma Patients.
   Ann Surg Oncol. 2026 Feb 4. doi: 10.1245/s10434-026-19161.
   PubMed        
   
   

   
   Br J Dermatol

5. BEAGLES E, Khattab S, Burke OM, Nguyen N, et al
   The Impact of Clinicopathologic Features on the Prognosis of Thin Melanomas: A Retrospective Cohort Analysis.
   Br J Dermatol. 2026 Feb 2:ljag034. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Cancer

6. LAWRENCE L
   Nine-year data show sustained benefit of nivolumab in patients with high-risk resected melanoma.
   Cancer. 2026;132:e70234.
   PubMed        
   
   

   
   Clin Cancer Res

7. ANSSTAS G, Khaddour K, Sudhaman S, Lin K, et al
   Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanoma.
   Clin Cancer Res. 2026 Feb 3. doi: 10.1158/1078-0432.CCR-25-3643.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

8. ZHAO Z, Peng K, Shen Y
   Refining Stage II Melanoma Risk Stratification Through Tumor-Infiltrating Lymphocyte Assessment.
   J Am Acad Dermatol. 2026 Feb 4:S0190-9622(26)00131.
   PubMed        
   
   
9. ADLER R, Burshtein JG, Marson JW, Rigel DS, et al
   Response to Reynolds, et al "Commentary on "Impact of climate and UV variables on melanoma incidence across United States counties".
   J Am Acad Dermatol. 2026 Jan 29:S0190-9622(26)00092.
   PubMed        
   
   
10. REYNOLDS CE, Fay AB, Rundle CW, Tripathi R, et al
    Commentary on "Impact of climate and UV variables on melanoma incidence across United States counties".
    J Am Acad Dermatol. 2026 Jan 29:S0190-9622(26)00091.
    PubMed        
    
    

    
    Melanoma Res

11. POZUELO-RUIZ M, de Unamuno-Bustos B, Navarro-Blanco F, Palacios-Diaz RD, et al
    Survival and toxicity profile of elderly melanoma patients treated with immune checkpoint inhibitors: a retrospective study from a tertiary care center.
    Melanoma Res. 2026 Feb 4. doi: 10.1097/CMR.0000000000001076.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum